Found 48 matching trials
A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer
PHASE1Background:
* PSA (prostate specific antigen) is a protein found on normal...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
A Phase II Trial of Neoadjuvant PD-1 Vaccine PD1-Vaxx in Operable MSI High Colorectal Cancer
PHASE2The aim of Neo-POLEM is to determine the rate of Major Pathological Respons...
Location
The Queen Elizabeth Hospital
Testing the SurVaxM Vaccine for Lung Cancer Prevention
PHASE2This phase II trial tests how well a survivin peptide vaccine called SurVax...
Location
Rocky Mountain Regional VA Medical Center
Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults
PHASE1Part I:
12 subjects will receive an open-label 500 µl subcutaneous injecti...
Location
University Hospital Tuebingen
Vaccination of High Risk Breast Cancer Patients
PHASE1The purpose of this study is to evaluate a new investigational cancer vacci...
Location
Highlands Oncology Group
Vaccination of Advanced-Stage Lung Cancer Patients
PHASE1The overarching purpose of this study is to evaluate the clinical efficacy ...
Location
University of Arkansas for Medical Sciences
Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision)
PHASE1The PerVision trial utilizes an approach of a patient-individual cancer vac...
Location
Pediatrics III, West German Cancer Centre, University Hospital
A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer
PHASE1This is a Phase I/II randomized study for subjects with recurrent ovarian, ...
Location
Abramson Cancer Center of the University of Pennsylvania
Randomized, Double Blind, Placebo-controlled Topical Resiquimod Adjuvant for NY-ESO-1 Protein Vaccination
PHASE1The study is designed to see if a course of injections containing the NY-ES...
Location
Icahn School of Medicine at Mount Sinai
Derivation of Tumor Specific Hybridomas
PHASE1This is a non-randomized, open-label study in patients with newly diagnosed...
Location
Multiple Locations